IMVTImmunovant, Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $24.50 (+0.00% today)

Market Cap: $4.99B

P/E (TTM): -9.60

Analyst Upside: 104.1%

Relative Strength (RS%): 1

-16.2% from 52-week high

Back to Scanner

IMVT

NASDAQRS 1Score 23

Immunovant, Inc.

HealthcareBiotechnology$4.99B1 setup passing
$24.50
0.0% ($0.00)
-16.2% from 52W High
P/E (TTM)
-9.60
Fwd P/E
PEG
Analyst Upside
+104.1%
EPS Growth
Gross Margin
0.0%
ROE
-65.8%
D/E
Div Yield
0.0%
Avg Volume
2.0M

Price Chart

Key Levels

SMA 200
$21.13
SMA 50
$25.82
Price
$24.50
52W High
$29.24
Target
$50.00

Setup Radar

1/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst